Antara Capital LP Aurinia Pharmaceuticals Inc. Transaction History

Antara Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$8.96 - $11.69 $4.48 Million - $5.85 Million	500,000 New	500,000 $4.84 Million
Q2 2022 Aug 15, 2022	SELL	$8.95 - $12.8 $1.69 Million - $2.41 Million	-188,621 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$10.05 - $22.48 $1.9 Million - $4.24 Million	188,621 New	188,621 $2.34 Million
Q2 2021 Aug 16, 2021	SELL	$10.0 - $14.52 $3.01 Million - $4.37 Million	-300,988 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$12.3 - $18.73 $3.7 Million - $5.64 Million	300,988 New	300,988 $3.91 Million
Q2 2020 Aug 14, 2020	SELL	$14.12 - $18.33 $4,236 - $5,498	-300 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$11.34 - $21.46 $3,402 - $6,438	300 New	300 $4,000

208

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Antara Capital LP, based on Form 13F filings with the SEC.

Stay updated on Antara Capital LP with notifications on news.